RAG8 peptide is an antagonist for protease-activated receptor 4 (PAR 4), which inhibits late-stage platelet activation, and reduces thrombosis without altering hemostasis or increasing bleeding risk. RAG8 peptide can be used for atherosclerosis research[
Molecular Weight:
1171.48
Formula:
C56H98N16O11
Target:
Protease Activated Receptor (PAR)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
